Creating advanced gene technologies to control malaria-carrying mosquitoes
Development of next-generation gene drive technologies for Anopheles population engineering
This study is exploring a new way to help control malaria by using special gene technology to change Anopheles mosquitoes, which spread the disease, so they either have fewer babies or can’t pass on malaria, especially to protect young children who are most at risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11092326 on NIH RePORTER |
What this research studies
This research focuses on developing innovative gene drive technologies using CRISPR to engineer populations of Anopheles mosquitoes, which are known to transmit malaria. By introducing genetic modifications that can either reduce the mosquito population or alter their ability to spread the malaria parasite, the project aims to provide a new method for controlling malaria outbreaks. The approach involves inserting a specific genetic sequence into the mosquito genome that can replicate and spread through the population, potentially leading to significant reductions in malaria transmission. This research is particularly relevant for young children, who are the most affected by malaria.
Who could benefit from this research
Good fit: Ideal candidates for this research are children under 11 years old living in malaria-endemic regions.
Not a fit: Patients who do not live in areas affected by malaria or who are over the age of 11 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce malaria transmission, leading to fewer cases and deaths, especially among vulnerable children.
How similar studies have performed: Other research has shown promise in using gene drive technologies for vector control, indicating potential success for this novel approach.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Bier, Ethan — University of California, San Diego
- Study coordinator: Bier, Ethan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.